In a new study, an international team led by the University of Bonn identified and further developed the novel single-domain antibodies (sdAbs) against SARS-CoV-2. The researchers also combined these single-domain antibodies intoRead More…
In a recent study, the scientists at UT Southwestern have developed a new method to study the molecular characteristics of T cells. The method, published on Nature Methods, makes it easier forRead More…
Recently, the phase 3 clinical trial results of T cell receptor (TCR) therapy, tebentafusp, have been released. The results showed that it reached the primary endpoint in the treatment of metastatic uvealRead More…
A new study published on eLife shows when T cells in the immune system find and identify targets, they release chemicals to attract more T cells, and then gather to help suppressRead More…
CD38 protein, which was discovered in 1980, is a type II transmembrane glycoprotein with a size of 46 kDa. The ligand of CD38 is CD31, also known as PECAM-1, which is aRead More…
In a new study, researchers from Humabs Biomed SA and the University of Washington found that an antibody that suppresses the associated coronavirus was identified for the first time in a bloodRead More…
Researchers from Charité-Universitätsmedizin Berlin, Berlin Institute of Health and Deutsches Rheuma-Forschungszentrum, together with other scientists, have shown how microbes help the immune system respond to pathogens. Without the relevant mediators, the metabolicRead More…
In a study published in Nature, scientists from St. Jude’s Children’s Research Hospital and other institutions have developed a new treatment strategy to effectively enhance cancer immunotherapy, which may effectively slow tumorRead More…
Incidence of lung cancer Lung cancer has the highest incidence of cancer in the world. According to WHO’ statistics, there are an estimated 18.1 million new cancer patients worldwide in 2018, ofRead More…
The high cost of cancer drugs makes it difficult for public and private health care systems to provide patients with up-to-date treatment. If this trend continues, it will be increasingly difficult forRead More…